• Synthon Biopharmaceuticals Relaunches as Byondis b3cnewswire
    April 23, 2020
    Synthon Biopharmaceuticals B.V., a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless cancers and autoimmune diseases, today announced that it is relaunching as Byondis.
PharmaSources Customer Service